TOOLS
Login to access your documents and resources.
Real estate
U.S. Strategic Lab
Overview
A life science investment strategy focused on opportunities in 10 key U.S. markets that seeks to deliver value-added investor returns.
Key features:
- An aging population, longer lifespans, rapid innovation, and robust public and private funding have contributed to swift demand growth in a sector for which we believe is structurally undersupplied
- Life science properties are a defensive asset class that is also more “work from home” resistant and less reliant on economic cycles
- Leverages both in-house life science investment experts and established strategic partnerships, many of which include exclusive rights of first opportunity (ROFO)
We believe the U.S. is in a time of unprecedented life science innovation. Tech advancements, coupled with fundamental demographic shifts, create compelling opportunities to invest in these highly regulated spaces behind the science.
Related artilces
Independent of the pandemic, life science research has been fueled by other macroeconomic tailwinds.
Volatile markets and rising rates reveal risks and opportunities for real estate investors.
In this issue, we explore buying opportunities in the market today: currency dispersions, the resurgence of necessity retail centers, changes in housing trends, regional and city diversification and the emerging sector of scientific lab space.
Our offices
